EichorEICHOR
Study identifier: NCT07011732 Synced from ClinicalTrials.gov · August 04, 2026
● Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Condition: Alzheimer Disease  ·  Sponsor: Bristol-Myers Squibb

PhasePhase 3
Planned participants426
Who can joinAll sexes, 55 Years to 90 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (158)

Imaging EndpointsScottsdale, Arizona, United StatesRecruiting
Advanced Research Center (ARC) - AnaheimAnaheim, California, United StatesRecruiting
Local Institution - 1637La Jolla, California, United StatesCompleted
The Neurology GroupPomona, California, United StatesRecruiting
Local Institution - 1639Torrance, California, United StatesActive Not Recruiting
Sunwise Clinical ResearchWalnut Creek, California, United StatesRecruiting
Local Institution - 1630Colorado Springs, Colorado, United StatesWithdrawn
Local Institution - 1622Maitland, Florida, United StatesNot Yet Recruiting
Local Institution - 1631Maitland, Florida, United StatesNot Yet Recruiting
Local Institution - 1666Merritt Island, Florida, United StatesNot Yet Recruiting
Local Institution - 1602Miami, Florida, United StatesNot Yet Recruiting
Local Institution - 1618Miami, Florida, United StatesNot Yet Recruiting

+ 146 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07011732